Cart
sales@molnova.com
GSK-2894631A
CAS No. 2101626-26-8
GSK-2894631A( HPGDS inhibitor 2 )
Catalog No. M23952 CAS No. 2101626-26-8
HPGDS inhibitor 2 is a potent, selective hematopoietic prostaglandin D synthase (h-pgds) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 260 | In Stock |
|
| 10MG | 410 | In Stock |
|
| 25MG | 678 | In Stock |
|
| 50MG | 954 | In Stock |
|
| 100MG | 1287 | In Stock |
|
| 500MG | 2574 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGSK-2894631A
-
NoteResearch use only, not for human use.
-
Brief DescriptionHPGDS inhibitor 2 is a potent, selective hematopoietic prostaglandin D synthase (h-pgds) inhibitor.
-
DescriptionHPGDS inhibitor 2 is a potent, selective hematopoietic prostaglandin D synthase (h-pgds) inhibitor, IC50 = 9.9 nm.
-
In Vitro——
-
In Vivo——
-
SynonymsHPGDS inhibitor 2
-
PathwayImmunology/Inflammation
-
TargetPGE synthase
-
RecptorhPGDS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2101626-26-8
-
Formula Weight378.41
-
Molecular FormulaC20H24F2N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:130mg/ml(343.54mM)
-
SMILESFC(F)OC1=CC=C2C(N=CC(C(N[C@@H]3CC[C@@H](C(C)(C)O)CC3)=O)=C2)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rc A , Dnd A , Yd A , et al. The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure[J]. Bioorganic & Medicinal Chemistry, 2020, 28( 23).
molnova catalog
related products
-
Crisdesalazine
Crisdesalazine (AAD-2004, AAD2004) is a derivative of aspirin that inhibits microsomal PGE(2) synthase-1 (mPGES-1) activity in response to both LPS-treated BV2 cell with IC50 of 230 nM and recombinant human mPGES-1 protein with IC50 of 249 nM in vitro.
-
PF-9184
PF-9184 is a potent, selective mPGES-1 (microsomal prostaglandin E synthase-1) inhibitor with IC50 of 16.5 nM.
-
HPGDS inhibitor 1
A potent, selective, oral hematopoietic prostaglandin D synthase (HPGDS) inhibitor with enzyme IC50 of 0.6 nM.
